NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,458 | -59.3% | 21,923 | -1.4% | 0.00% | – |
| Q2 2023 | $57,583 | -50.6% | 22,233 | -22.2% | 0.00% | – |
| Q1 2023 | $116,590 | -17.9% | 28,576 | +1.1% | 0.00% | – |
| Q4 2022 | $141,930 | -88.7% | 28,273 | -70.5% | 0.00% | -100.0% |
| Q3 2022 | $1,252,000 | +37.6% | 95,686 | +34.8% | 0.00% | 0.0% |
| Q2 2022 | $910,000 | -5.1% | 70,996 | +12.9% | 0.00% | 0.0% |
| Q1 2022 | $959,000 | -59.1% | 62,888 | -22.1% | 0.00% | -50.0% |
| Q1 2021 | $2,346,000 | +25.1% | 80,692 | +30.4% | 0.00% | 0.0% |
| Q4 2020 | $1,875,000 | +83.3% | 61,875 | -3.7% | 0.00% | +100.0% |
| Q3 2020 | $1,023,000 | -10.5% | 64,282 | +11.0% | 0.00% | -50.0% |
| Q2 2020 | $1,143,000 | – | 57,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |